Life Scientist > Biotechnology

TGA approves Novavax vaccine, oral treatments for COVID-19

21 January, 2022 by Lauren Davis

The TGA has granted provisional approval for the first two oral treatments for COVID-19 in Australia, as well as the much-anticipated Novavax vaccine.

Moderna bringing mRNA vaccine manufacturing to Victoria

15 December, 2021

A sovereign onshore vaccine manufacturing facility will be built in Victoria as part of a long-term strategic partnership to increase preparedness for possible future pandemics.

Anticancer drug prevents heart damage from chemotherapy

14 December, 2021

Zantrene is able to protect heart muscle cells from death, while improving the killing of breast cancer cells, when used in combination with the anthracycline known as doxorubicin.

Pfizer and Moderna boosters now available from five months

13 December, 2021

Australian adults can now receive a Moderna or Pfizer COVID-19 booster shot after five months, while Pfizer primary doses will be available to children aged 5–11.

TGA approves booster doses of Moderna vaccine

09 December, 2021

The TGA has provisionally approved a booster dose of the Moderna COVID-19 vaccine for individuals 18 years and older, as well as a monoclonal antibody treatment.

TGA provisionally approves Pfizer vaccine for children

06 December, 2021

Subject to final recommendations from ATAGI, the Australian Government will start rolling out the Pfizer vaccine to 5- to 11-year-olds from 10 January 2022.

Scientists create Australia's first mRNA vaccine candidate

02 December, 2021 by Lauren Davis

Victorian scientists and manufacturers have created Australia's first mRNA COVID-19 vaccine candidate — and first ever mRNA drug product.

Wearable injector can detect, reverse opioid overdose

25 November, 2021

The device, worn on the stomach, senses when a person stops breathing and injects naloxone — a lifesaving antidote that can restore respiration.

Penicillin helps treat rheumatic heart disease in children

18 November, 2021

A regular, affordable antibiotic treatment has been found to significantly reduce the risk of underlying rheumatic heart disease progression in children.

Gold nanoparticles help treat prostate cancer patients

16 November, 2021

The treatment can make cancerous cells up to 30% more receptive to radiotherapy while simultaneously reducing adverse side effects that limit quality of life.

Smart bandage enables onsite chronic wound monitoring

08 November, 2021

The smart wearable sensor can conduct real-time, point-of-care assessment of chronic wounds wirelessly via an app.

TGA approves Pfizer COVID-19 booster vaccine for Aus adults

27 October, 2021 by Lauren Davis

The TGA provisionally approves a booster dose of Pfizer's vaccine for individuals 18 years and older, while advisers to the US FDA recommend the vaccine for children aged 5–11.

RNA pilot manufacturing facility announced for NSW

22 October, 2021

The $96 million pilot facility will develop mRNA and RNA drugs and vaccines, in order to better combat disease and save lives.

Outsourcing single-use technologies to accelerate speed to market

21 October, 2021

To fast-track time to market and gain a competitive edge, pharmaceutical development companies are increasingly implementing single-use technologies.

Empowering researchers to develop genetic medicines

18 October, 2021

The Precision Nanosystems NanoAssemblr is a platform of technologies designed to encapsulate a drug or genetic material.

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd